• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦黑色素瘤行大体全切除术后手术入路和切缘状态与肿瘤学结局的相关性。

Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.

机构信息

Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

出版信息

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1220-1227. doi: 10.1001/jamaoto.2017.2011.

DOI:10.1001/jamaoto.2017.2011
PMID:29049462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5808194/
Abstract

IMPORTANCE

Sinonasal mucosal melanoma (SMM) is a rare malignant neoplasm characterized by a poor prognosis despite aggressive intervention including wide surgical resection. Margin status has previously been cited as an important prognostic factor for local control and overall survival (OS) in patients who undergo either an open or endoscopic surgical approach. No comparisons have been made, however, in patients who have undergone gross total resection with or without positive margins.

OBJECTIVE

To assess the association of margin status and surgical approach with oncologic outcomes in patients with SMM undergoing gross total resection.

DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, patients with SMM without evidence of regional or distant disease treated with curative intent in part or full at Memorial Sloan Kettering Cancer Center from 1998 through 2016 were retrospectively assessed. Demographic data, prognostic information, and surgical pathology were reviewed. Operative reports and imaging were used to confirm gross total resection of local disease.

EXPOSURES

Surgical techniques including open maxillectomy, craniofacial resection, and endoscopic resection.

MAIN OUTCOMES AND MEASURES

Three-year local recurrence-free survival (LRFS), disease-free survival (DFS), and OS were calculated using the Kaplan-Meier method. Univariate and multivariable analyses of outcomes were carried out using the Cox proportional hazard regression method.

RESULTS

Seventy-two patients (39 [54%] female; mean [SD] age, 67 [12] years) met the eligibility criteria. Thirty-eight patients (53%) underwent open partial or total maxillectomy with or without ethmoidectomy or sphenoidectomy via a transfacial approach. Fourteen patients (19%) had a more extensive craniofacial approach, and 20 patients (28%) underwent endoscopic resection. The 3-year OS for all patients was 52%. The absolute 3-year difference between patients with open/craniofacial resection vs endoscopic resection for LRFS, DFS, and OS was 11% (95% CI, −21% to 43%), 16% (95% CI, −7% to 39%), and 12% (95% CI, −18% to 41%), respectively. The absolute 3-year difference between patients with a negative margin and patients with a positive margin for LRFS, DFS, and OS was 18% (95% CI, −9% to 45%), 5% (95% CI, −17% to 27%), and 15% (95% CI, −9% to 39%), respectively. Multivariable analysis revealed that none of the adjusted variables (margin status, tumor stage, or surgical approach) were significantly associated with OS.

CONCLUSIONS AND RELEVANCE

Outcomes for patients with SMM remain poor regardless of operative approach or postoperative margin status.

摘要

重要性

尽管采用了包括广泛手术切除在内的积极干预措施,但是鼻窦黏膜黑色素瘤(SMM)仍是一种预后不良的罕见恶性肿瘤。在接受开放式或内镜手术治疗的患者中,切缘状态先前被认为是局部控制和总生存(OS)的重要预后因素。然而,尚未在接受完全手术切除且切缘阳性或阴性的患者中进行比较。

目的

评估 SMM 患者在接受完全手术切除时切缘状态和手术方法与肿瘤学结果的关系。

设计、设置和参与者:在这项回顾性队列研究中,对 1998 年至 2016 年期间在 Memorial Sloan Kettering 癌症中心接受根治性治疗的局部疾病部分或全部接受治疗的无区域或远处疾病证据的 SMM 患者进行评估。回顾性评估了患者的人口统计学数据、预后信息和手术病理学资料。使用手术报告和影像学检查来确认局部疾病的完全手术切除。

暴露因素

包括开放式上颌骨切除术、颅面切除术和内镜切除术在内的手术技术。

主要结果和测量

使用 Kaplan-Meier 法计算 3 年局部无复发生存率(LRFS)、无病生存率(DFS)和 OS。使用 Cox 比例风险回归法进行单变量和多变量分析。

结果

72 名患者(39 [54%] 名女性;平均[SD]年龄,67 [12] 岁)符合入选标准。38 名患者(53%)接受了开放式部分或全部上颌骨切除术,联合或不联合经面入路的鼻旁窦切除术或蝶窦切除术。14 名患者(19%)采用了更广泛的颅面入路,20 名患者(28%)接受了内镜切除术。所有患者的 3 年 OS 为 52%。在接受开放式/颅面切除术与内镜切除术的患者中,LRFS、DFS 和 OS 的 3 年绝对差异分别为 11%(95%CI,-21%至 43%)、16%(95%CI,-7%至 39%)和 12%(95%CI,-18%至 41%)。LRFS、DFS 和 OS 的阴性切缘与阳性切缘患者的 3 年绝对差异分别为 18%(95%CI,-9%至 45%)、5%(95%CI,-17%至 27%)和 15%(95%CI,-9%至 39%)。多变量分析显示,调整后的变量(切缘状态、肿瘤分期或手术方法)均与 OS 无显著相关性。

结论和相关性

无论手术方法还是术后切缘状态如何,SMM 患者的预后仍然较差。

相似文献

1
Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.鼻窦黑色素瘤行大体全切除术后手术入路和切缘状态与肿瘤学结局的相关性。
JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1220-1227. doi: 10.1001/jamaoto.2017.2011.
2
Endoscopic resection of sinonasal mucosal melanoma has comparable outcomes to open approaches.鼻窦黏膜黑色素瘤的内镜切除术与开放手术方法的疗效相当。
Am J Rhinol Allergy. 2017 May 1;31(3):200-204. doi: 10.2500/ajra.2017.31.4435.
3
Outcome of sinonasal melanoma: clinical experience and review of the literature.鼻腔鼻窦黑色素瘤的预后:临床经验和文献复习。
Head Neck. 2010 Oct;32(10):1385-92. doi: 10.1002/hed.21340.
4
Endoscopic Resection of Sinonasal and Ventral Skull Base Malignancies.鼻鼻窦及颅底腹侧恶性肿瘤的内镜切除术
Otolaryngol Clin North Am. 2017 Apr;50(2):273-285. doi: 10.1016/j.otc.2016.12.005. Epub 2017 Feb 3.
5
[Primary melanoma of the nasal and paranasal sinus mucosa].[鼻腔及鼻窦黏膜原发性黑色素瘤]
Khirurgiia (Sofiia). 2001;57(3-4):65-6.
6
Impact of margin status on survival after surgery for sinonasal squamous cell carcinoma.鼻窦鳞状细胞癌手术后切缘状态对生存的影响。
Int Forum Allergy Rhinol. 2019 Oct;9(10):1205-1211. doi: 10.1002/alr.22415. Epub 2019 Aug 22.
7
Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach.鼻窦鳞状细胞癌的边缘:预测因素、结果和内镜方法。
Laryngoscope. 2020 Jun;130(6):E388-E396. doi: 10.1002/lary.28315. Epub 2019 Nov 22.
8
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.局限性鼻窦黏膜黑色素瘤:预后以及与分期、放疗和正电子发射断层扫描反应的相关性
Head Neck. 2016 Sep;38(9):1310-7. doi: 10.1002/hed.24435. Epub 2016 Apr 4.
9
Sinonasal mucosal melanoma: A 44-case study and literature analysis.鼻窦黏膜黑色素瘤:一项44例病例研究及文献分析。
Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Sep;134(4):237-242. doi: 10.1016/j.anorl.2017.02.003. Epub 2017 Apr 22.
10
Outcomes of sinonasal mucosal melanomas with endoscopic and open resection: a retrospective cohort study.内镜和开放切除治疗鼻窦黏膜黑色素瘤的疗效:一项回顾性队列研究。
J Neurooncol. 2020 Dec;150(3):387-392. doi: 10.1007/s11060-020-03449-0. Epub 2020 Mar 29.

引用本文的文献

1
Surgical margin assessment and prognostic impact in sinonasal cancers: a systematic review and meta-analysis.鼻窦癌手术切缘评估及其预后影响:一项系统评价与荟萃分析
Acta Otorhinolaryngol Ital. 2025 May;45(Suppl. 1):S25-S55. doi: 10.14639/0392-100X-suppl.1-45-2025-N1127.
2
Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis.鼻窦黏膜黑色素瘤的生存结局:系统评价与荟萃分析
J Pers Med. 2024 Nov 26;14(12):1120. doi: 10.3390/jpm14121120.
3
Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.多模态治疗联合免疫检查点抑制剂治疗鼻腔鼻窦黏膜黑色素瘤:一项回顾性单中心真实世界研究数据。
Eur Arch Otorhinolaryngol. 2023 Sep;280(9):4215-4223. doi: 10.1007/s00405-023-08015-8. Epub 2023 Jun 5.
4
A nomogram for predicting overall survival of patients with sinonasal melanoma: A population-based study.预测鼻窦黑色素瘤患者总生存期的列线图:一项基于人群的研究。
Laryngoscope Investig Otolaryngol. 2022 Nov 22;7(6):1837-1848. doi: 10.1002/lio2.951. eCollection 2022 Dec.
5
Stimulated Raman Histology for Rapid Intra-Operative Diagnosis of Sinonasal and Skull Base Tumors.激发 Raman 组织学用于快速术中诊断鼻腔鼻窦和颅底肿瘤。
Laryngoscope. 2022 Nov;132(11):2142-2147. doi: 10.1002/lary.30233. Epub 2022 May 30.
6
Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.鼻窦恶性肿瘤的外科治疗结果-单中心综合癌症中心经验。
Head Neck. 2022 Apr;44(4):933-942. doi: 10.1002/hed.26989. Epub 2022 Jan 25.
7
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment.鼻腔鼻窦肿瘤的分子标志物:诊断与治疗的新领域。
Curr Oncol Rep. 2022 Jan;24(1):55-67. doi: 10.1007/s11912-021-01154-3. Epub 2022 Jan 20.
8
Evolution in Sinonasal Mucosal Melanoma Management.鼻窦黏膜黑色素瘤治疗的进展
J Neurol Surg Rep. 2022 Jan 10;83(1):e1-e2. doi: 10.1055/s-0041-1741380. eCollection 2022 Jan.
9
Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy.接受全身免疫治疗的鼻窦黏膜黑色素瘤患者的手术治疗
J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e148-e154. doi: 10.1055/s-0040-1701219. Epub 2020 Feb 7.
10
Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma.我们的患者情况是否有所改善?单机构对鼻窦黏膜黑色素瘤不断演变的管理模式的经验。
Oral Oncol. 2021 Jan;112:105006. doi: 10.1016/j.oraloncology.2020.105006. Epub 2020 Sep 18.

本文引用的文献

1
Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.黏膜黑色素瘤患者的临床情况、预后及新治疗选择:75例患者的回顾性分析
Medicine (Baltimore). 2017 Jan;96(1):e5753. doi: 10.1097/MD.0000000000005753.
2
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.局限性鼻窦黏膜黑色素瘤:预后以及与分期、放疗和正电子发射断层扫描反应的相关性
Head Neck. 2016 Sep;38(9):1310-7. doi: 10.1002/hed.24435. Epub 2016 Apr 4.
3
Sinonasal mucosal melanoma: A 12-year experience of 58 cases.鼻窦黏膜黑色素瘤:58例患者的12年经验。
Head Neck. 2016 Apr;38 Suppl 1:E1737-45. doi: 10.1002/hed.24309. Epub 2015 Dec 17.
4
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.纳武单抗与伊匹单抗联合用药或单药治疗初治黑色素瘤
N Engl J Med. 2015 Sep 24;373(13):1270-1. doi: 10.1056/NEJMc1509660.
5
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.淋巴结辅助放疗对比观察仅用于淋巴结清扫术后有进一步淋巴结复发高风险的黑色素瘤患者(ANZMTG 01.02/TROG 02.01):一项 3 期随机对照临床试验的 6 年随访结果。
Lancet Oncol. 2015 Sep;16(9):1049-1060. doi: 10.1016/S1470-2045(15)00187-4. Epub 2015 Jul 20.
6
Recent advances in liver resection for hepatocellular carcinoma.肝细胞癌肝切除的最新进展
Front Surg. 2014 Jun 16;1:21. doi: 10.3389/fsurg.2014.00021. eCollection 2014.
7
Surgical management of recurrent sinonasal mucosal melanoma: endoscopic or transfacial resection.复发性鼻窦黏膜黑色素瘤的外科治疗:内镜手术或经面部切除术。
Eur Arch Otorhinolaryngol. 2015 Feb;272(2):351-6. doi: 10.1007/s00405-014-3119-y. Epub 2014 Jun 1.
8
Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma.Ipilimumab 3mg/kg 在预处理、转移性、黏膜黑色素瘤患者中的疗效和安全性。
Eur J Cancer. 2014 Jan;50(1):121-7. doi: 10.1016/j.ejca.2013.09.007. Epub 2013 Oct 4.
9
Survival in Sinonasal Melanoma: A Meta-analysis.鼻窦黑色素瘤的生存率:一项荟萃分析。
J Neurol Surg B Skull Base. 2012 Jun;73(3):157-62. doi: 10.1055/s-0032-1301400.
10
Rising incidence of mucosal melanoma of the head and neck in the United States.美国头颈部黏膜黑色素瘤的发病率呈上升趋势。
J Skin Cancer. 2012;2012:231693. doi: 10.1155/2012/231693. Epub 2012 Dec 2.